Senior Director, Finance Transformation

BeiGene•Hopewell, VA

1d•Hybrid

About The Position

BeOne Medicines USA, Inc. seeks a Sr. Director, Finance Transformation in Pennington, NJ. This role will serve as the Senior Director of BeOne’s Finance transformation initiative for a publicly traded biopharma company with $5B in annual revenues and globally integrated finance and accounting, research and development, commercial, and manufacturing operations. The position provides overall leadership, governance, and execution oversight for enterprise-wide Finance transformation initiatives, including zero-based budgeting, redesigning the data model, financial systems and global process improvement programs, as well as development of business cases for new or redesigned operating models. The role defines, maintains, and executes a multi-year transformation roadmap aligned with enterprise strategy, budget management priorities, and evolving operating models. This includes defining scope/analytical requirements/sequencing of initiatives, managing interdependencies, coordinating cross-functional inputs, establishing milestones, and tracking progress against delivery objectives. The Senior Director will design globally standardized, fit-for-purpose financial processes, governance structures, and operating models, including redesigning financial management reports, defining and implementing allocation methodologies, FP&A process stewardship, and financial master data management governance. This role facilitates driving recommendations for finance transformation initiatives and ensures the implementation of decisions made by the Finance Leadership Team meets requirements, while aligning with regulatory, operational, and geographic complexity. The Senior Director will lead the development of analytical context and presentations for the CFO, Finance Leadership Team, and other executives to inform progress, risks, investment trade-offs, and drive decision-making. Additionally, the role involves leading and developing team members, including setting objectives, coaching and mentoring, and performance management. The Senior Director will oversee and manage external consultants and vendors supporting Finance transformation initiatives, including scope definition, quality assurance of deliverables, integration with internal teams, and cost management. Finally, the role develops and delivers structured financial training and education programs for internal stakeholders with varying levels of financial expertise, focused on enterprise financial concepts, transformation objectives, analytical interpretation, and decision-making implications.

Requirements

Master’s degree (or its foreign degree equivalent) in Finance, Business Administration, Management, or a related discipline, and three (3) years of experience in the job offered or in any occupation in related field
Synthesizing and analyzing corporate strategy and related financial implications, presenting to senior management for key decision making.
Providing strategic advice for external and/or internal clients in a variety of industries including pharma/biotech, technology and other sectors of fast growth.
Working with financial statements and understanding inter-dependencies including building financial models and economic analysis, including break-even and return on investment (ROI).
Coordinating with and influencing cross-functional teams and colleagues outside of the core project team, to communicate and clarify business objectives, identify actionable next steps, define ownership and timing expectation of action items, and ensure timely implementation of actions to drive results.
Managing multiple business projects with independent objectives and deadlines at the same time.
Biopharma industry knowledge.
Financial management for public company (financial planning including LRP, AOP, managing reporting cycles and zero-based budgeting).
Leading finance transformation projects (financial systems, data model, process stewardship).
Cross-functional finance expertise within a publicly traded biopharma company.
Any suitable combination of education, training and/or experience is acceptable.

Responsibilities

Provide overall leadership, governance, and execution oversight for enterprise-wide Finance transformation initiatives, including zero-based budgeting, redesigning the data model, financial systems and global process improvement programs as well as development of business cases for new or redesigned operating models.
Define, maintain, and execute a multi-year transformation roadmap aligned with enterprise strategy, budget management priorities, and evolving operating models; including defining scope/analytical requirements/sequencing of initiatives, managing interdependencies, coordinating cross-functional inputs, establishing milestones and tracking progress against delivery objectives.
Design globally standardized, fit-for-purpose financial processes, governance structures, and operating models, including redesigning financial management reports, defining and implementing allocation methodologies, FP&A process stewardship, and financial master data management governance.
Facilitate driving recommendations for finance transformation initiatives and ensure the implementation of decisions made by the Finance Leadership Team meets requirements, while aligning with regulatory, operational, and geographic complexity.
Lead development of analytical context and presentations for the CFO, Finance Leadership Team, and other executives to inform progress, risks, investment trade-offs, and drive decision-making.
Lead and develop team members, including setting objectives, coaching and mentoring, and performance management.
Oversee and manage external consultants and vendors supporting Finance transformation initiatives, including scope definition, quality assurance of deliverables, integration with internal teams, and cost management.
Develop and deliver structured financial training and education programs for internal stakeholders with varying levels of financial expertise, focused on enterprise financial concepts, transformation objectives, analytical interpretation, and decision-making implications.